UNCY
Unicycive Therapeutics Inc
4.10$
+1.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.8% | +246.3% | -139.8% | – | +8.9% | +0.7% | +2.2% | +7.2% | +2.0% | +39.7% | +67.8% | – | |
| – | -40.8% | -5.1% | +22.8% | -5.6% | -3.8% | -3.3% | +1.4% | +27.8% | +6.4% | -3.0% | +281.6% | – | |
| – | +274.9% | +68.9% | -74.6% | -960.4% | – | -207.1% | – | – | -969.2% | – | -233.8% | – | |
| – | – | – | +233.3% | +20.0% | -8.3% | -27.3% | -62.5% | -66.7% | -100.0% | – | -87.5% | – | |
| – | – | – | +233.3% | +20.0% | -8.3% | -27.3% | -62.5% | -66.7% | +603,450.0% | -57.3% | -99.6% | – | |
| – | – | -76.0% | +426.4% | -81.0% | +0.0% | – | – | – | – | – | – | – | |
| – | -212.9% | – | – | -200.0% | – | – | – | – | – | – | – | – | |
| – | +302.0% | – | -101.8% | -80.6% | – | +597.5% | +331.4% | +139.7% | -74.9% | +196.2% | -26.2% | – | |
| – | – | – | -118.2% | – | – | – | – | +696.2% | -166.3% | – | -16.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.